<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue https://jats.nlm.nih.gov/publishing/1.2/xsd/JATS-journalpublishing1-mathml3.xsd?><?DTDIdentifier.IdentifierType nschema?><?SourceDTD.DTDName JATS-journalpublishing1-mathml3.xsd?><?SourceDTD.Version 1.2?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Beilstein J Org Chem</journal-id><journal-id journal-id-type="iso-abbrev">Beilstein J Org Chem</journal-id><journal-title-group><journal-title>Beilstein Journal of Organic Chemistry</journal-title></journal-title-group><issn pub-type="epub">1860-5397</issn><publisher><publisher-name>Beilstein-Institut</publisher-name><publisher-loc>Trakehner Str. 7-9, 60487 Frankfurt am Main, Germany</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7607426</article-id><article-id pub-id-type="pmid">33178356</article-id><article-id pub-id-type="doi">10.3762/bjoc.16.216</article-id><article-categories><subj-group subj-group-type="heading"><subject>Full Research Paper</subject></subj-group><subj-group subj-group-type="topic"><subject>Chemistry</subject><subj-group subj-group-type="topic"><subject>Organic Chemistry</subject></subj-group></subj-group></article-categories><title-group><article-title>Vicinal difluorination as a C=C surrogate: an analog of piperine with enhanced solubility, photostability, and acetylcholinesterase inhibitory activity</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lizarme-Salas</surname><given-names>Yuvixza</given-names></name><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6964-8129</contrib-id><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ariawan</surname><given-names>Alexandra Daryl</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ratnayake</surname><given-names>Ranjala</given-names></name><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5980-2070</contrib-id><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Luesch</surname><given-names>Hendrik</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Finch</surname><given-names>Angela</given-names></name><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4598-6745</contrib-id><xref ref-type="aff" rid="A3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hunter</surname><given-names>Luke</given-names></name><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8678-3602</contrib-id><email>l.hunter@unsw.edu.au</email><xref ref-type="aff" rid="A1">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>O'Hagan</surname><given-names>David</given-names></name><role>Guest Editor</role></contrib></contrib-group><aff id="A1"><label>1</label>School of Chemistry, University of New South Wales (UNSW), Sydney NSW 2052, Australia</aff><aff id="A2"><label>2</label>Department of Medicinal Chemistry and Center for Natural Products, Drug Discovery and Development (CNPD3), University of Florida, Gainesville FL 32610, United States</aff><aff id="A3"><label>3</label>School of Medical Sciences, University of New South Wales (UNSW), Sydney NSW 2052, Australia</aff><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2020</year></pub-date><volume>16</volume><fpage>2663</fpage><lpage>2670</lpage><ext-link ext-link-type="doi" xlink:href="10.3762/bjoc.16.216">10.3762/bjoc.16.216</ext-link><history><date date-type="received"><day>12</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>16</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020, Lizarme-Salas et al.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Lizarme-Salas et al.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license license-type="Beilstein"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://www.beilstein-journals.org/bjoc/terms</ali:license_ref><license-p>This is an Open Access article under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0">https://creativecommons.org/licenses/by/4.0</ext-link>). Please note that the reuse, redistribution and reproduction in particular requires that the authors and source are credited.</license-p><license-p>The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (<ext-link ext-link-type="uri" xlink:href="https://www.beilstein-journals.org/bjoc/terms">https://www.beilstein-journals.org/bjoc/terms</ext-link>)</license-p></license></permissions><abstract><p>Piperine, a natural product derived from peppercorns, has a variety of biological activities that make it an attractive lead compound for medicinal chemistry. However, piperine has some problematic physicochemical properties including poor aqueous solubility and a susceptibility to UV-induced degradation. In this work, we designed an analog of piperine in which the central conjugated hydrocarbon chain is replaced with a vicinal difluoroalkane moiety. We show that this fluorinated analog of piperine has superior physicochemical properties, and it also has higher potency and selectivity towards one particular drug target, acetylcholinesterase. This work highlights the potential usefulness of the <italic>threo</italic>-difluoroalkane motif as a surrogate for <italic>E</italic>-alkenes in medicinal chemistry.</p></abstract><kwd-group kwd-group-type="author"><kwd>Alzheimer's disease</kwd><kwd>bioisostere</kwd><kwd>conformational analysis</kwd><kwd>gauche effect</kwd><kwd>stereoselective synthesis</kwd></kwd-group></article-meta><notes><p>This article is part of the thematic issue "Organo-fluorine chemistry V".</p></notes></front><body><sec><title>Introduction</title><p>Piperine (<bold>1</bold>, <xref ref-type="fig" rid="F1">Figure 1</xref>) is a well-known natural product that is derived from peppercorns [<xref rid="R1" ref-type="bibr">1</xref>&#x02013;<xref rid="R3" ref-type="bibr">3</xref>]. Many biological studies of <bold>1</bold> have been carried out, and these studies have led to a diverse array of biological activities being claimed for this compound [<xref rid="R4" ref-type="bibr">4</xref>&#x02013;<xref rid="R9" ref-type="bibr">9</xref>]. For example, <bold>1</bold> is reported to exhibit inhibitory activity towards both acetylcholinesterase (AChE) and &#x003b2;-secretase (BACE-1), which suggests that <bold>1</bold> could hold promise as a dual mechanism-of-action treatment for Alzheimer&#x02019;s disease [<xref rid="R4" ref-type="bibr">4</xref>,<xref rid="R10" ref-type="bibr">10</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref>].</p><fig id="F1" position="float"><label>Figure 1</label><caption><p>The natural product piperine (<bold>1</bold>) is the inspiration for this work; the crystal structure is shown [<xref rid="R14" ref-type="bibr">14</xref>]. In this work, a hypothetical analog <bold>2</bold> was designed to mimic parent compound <bold>1</bold>. The predicted low-energy rotamers of <bold>2</bold> about the F&#x02013;C&#x02013;C&#x02013;F and F&#x02013;C&#x02013;C=O bonds are shown; rotamers I and IV give the best mimicry of <bold>1</bold>.</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g002"/></fig><p>However, piperine (<bold>1</bold>) has some limitations as a drug lead. For example, it has poor solubility, and it is susceptible to photoisomerization of the conjugated system [<xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R17" ref-type="bibr">17</xref>]. This prompted us to consider whether there was another structural motif that could (i) mimic the extended geometry of an <italic>E-</italic>alkene, (ii) impart better solubility, and (iii) be more stable in the presence of UV light. Such a C=C surrogate might offer an improved lead compound for the development of drugs to treat Alzheimer&#x02019;s disease.</p><p>Stereoselective fluorination is an emerging strategy for controlling the conformations of organic molecules. The highly polarized C&#x02013;F bond tends to align in predictable ways with adjacent functional groups, due to a combination of hyperconjugative and/or dipolar interactions [<xref rid="R18" ref-type="bibr">18</xref>&#x02013;<xref rid="R21" ref-type="bibr">21</xref>]. This knowledge led us to propose the hypothetical analog <bold>2</bold> (<xref ref-type="fig" rid="F1">Figure 1</xref>) as a potential mimic of <bold>1</bold>. The analog <bold>2</bold> contains a saturated alkyl chain with two vicinal C&#x02013;F bonds in the &#x003b1;/&#x003b2; positions relative to the amide moiety. The presence of a vicinal difluoride moiety within an alkyl chain is known to favour rotamers in which the C&#x02013;F bonds align <italic>gauche</italic> (I and II, <xref ref-type="fig" rid="F1">Figure 1</xref>) [<xref rid="R22" ref-type="bibr">22</xref>]. Separately, the presence of fluorine on the &#x003b1;-carbon of a tertiary amide is known to restrict the C<sub>&#x003b1;</sub>&#x02013;C(O) bond to a small set of low-energy rotamers (III&#x02013;V, <xref ref-type="fig" rid="F1">Figure 1</xref>) [<xref rid="R23" ref-type="bibr">23</xref>]. Intriguingly, studies of simple molecules containing either F&#x02013;C&#x02013;C&#x02013;F or F&#x02013;C&#x02013;C=O motifs have shown that the rotamer populations can change, depending on the polarity of the solvent [<xref rid="R22" ref-type="bibr">22</xref>&#x02013;<xref rid="R23" ref-type="bibr">23</xref>]. The rotamers I and IV (<xref ref-type="fig" rid="F1">Figure 1</xref>, boxed) would appear to provide the closest structural match with compound <bold>1</bold>, but in a highly polar medium the more polar rotamers II and V might predominate. Of course, the contiguous positioning of the F&#x02013;C&#x02013;C&#x02013;F and F&#x02013;C&#x02013;C=O moieties within the same molecule (<bold>2</bold>) means that these moieties would not function independently, but rather would likely influence one another, adding another layer of complexity. Finally, it is interesting to consider whether the microenvironment of a protein binding site could also change the relative energies of the various F&#x02013;C&#x02013;C&#x02013;F and F&#x02013;C&#x02013;C=O rotamers, offering the possibility that analog <bold>2</bold> might be an effective conformational mimic of <bold>1</bold> in some environments but not in others.</p><p>Herein, we describe the optimisation of a synthetic route to compound <bold>2</bold>, the conformational analysis of this molecule by NMR and molecular modelling studies, a comparison of the photostabilities of parent compound <bold>1</bold> vs derivative <bold>2</bold>, and a comparison of the inhibitory activities of <bold>1</bold> vs <bold>2</bold> towards both AChE and BACE-1.</p></sec><sec><title>Results and Discussion</title><sec><title>Synthesis</title><p>Jacobsen and co-workers have recently described a method for the one-step, diastereoselective 1,2-difluorination of alkenes, mediated by a hypervalent iodine catalyst [<xref rid="R24" ref-type="bibr">24</xref>]. The substrate scope of the Jacobsen method has certain constraints but their original report did include some examples of &#x003b1;,&#x003b2;-unsaturated amides, and so we were motivated to investigate the method in this work, using compound <bold>3</bold> [<xref rid="R25" ref-type="bibr">25</xref>] as the substrate (<xref ref-type="fig" rid="C1">Scheme 1</xref>). We recognized that the product of this reaction would most likely be the unwanted <italic>erythro</italic>-isomer <bold>6</bold> but we nevertheless deemed it a worthwhile preliminary investigation. Disappointingly, the treatment of the precursor <bold>3</bold> with pyridine&#x000b7;HF and either catalyst <bold>4</bold> or <bold>5</bold> at room temperature for two days gave no discernible reaction, and the starting material <bold>3</bold> was recovered intact. Warming the reaction mixture to 50 &#x000b0;C caused the disappearance of <bold>3</bold> but the formation of an intractable mixture of products. We were forced to conclude that the rather complex structure of <bold>3</bold> was incompatible with the Jacobsen catalytic system.</p><fig id="C1" position="float"><label>Scheme 1</label><caption><p>The attempted synthesis of <bold>6</bold> (a diastereoisomer of <bold>2</bold>) via a one-step 1,2-difluorination reaction [<xref rid="R24" ref-type="bibr">24</xref>]. Py = pyridine; <italic>m</italic>-CPBA = <italic>m</italic>-chloroperbenzoic acid, DCM = dichloromethane.</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g006"/></fig><p>Since the one-step difluorination method (<xref ref-type="fig" rid="C1">Scheme 1</xref>) was unsuccessful, we decided to pursue a stepwise fluorination approach [<xref rid="R26" ref-type="bibr">26</xref>&#x02013;<xref rid="R27" ref-type="bibr">27</xref>] (<xref ref-type="fig" rid="C2">Scheme 2</xref>). Thus, the allylic alcohol <bold>7</bold> [<xref rid="R28" ref-type="bibr">28</xref>] was protected as the benzyl ether then subjected to a Sharpless asymmetric dihydroxylation reaction to furnish the diol <bold>8</bold> in modest yield. The diol <bold>8</bold> was then converted into the cyclic sulfate <bold>9</bold>, which was ring-opened using TBAF to furnish the fluorohydrin <bold>10</bold>. A Mosher ester analysis of the fluorohydrin <bold>10</bold> suggested that the earlier dihydroxylation reaction had proceeded with 90% ee. The deoxyfluorination of <bold>10</bold> was then attempted using several reagents including DeoxoFluor, DeoxoFluor in combination with TMS-morpholine [<xref rid="R29" ref-type="bibr">29</xref>], and PyFluor [<xref rid="R30" ref-type="bibr">30</xref>]. The optimal yield of the <italic>threo</italic>-difluoroalkane <bold>11</bold> was obtained with DeoxoFluor at elevated temperature (<xref ref-type="fig" rid="C2">Scheme 2</xref>). A side-product in this fluorination reaction was the tricyclic compound <bold>12</bold>, which presumably formed through an electrophilic aromatic substitution reaction of the activated alcohol intermediate. The inclusion of TMS-morpholine [<xref rid="R29" ref-type="bibr">29</xref>] reduced the formation of this side-product but did not lead to an overall increase in the yield of <bold>11</bold>. Despite the modest optimised yield of the difluoroalkane <bold>11</bold>, a sufficient quantity of this material was secured to continue with the synthesis. The hydrogenolysis of the benzyl ether of <bold>11</bold> provided the primary alcohol <bold>13</bold>, which only needed to be oxidised to the carboxylic acid <bold>14</bold> then coupled to piperidine in order to deliver the target compound, <bold>2</bold>. However, the oxidation of <bold>13</bold> proved to be unexpectedly troublesome. Mild oxidising agents caused incomplete consumption of <bold>13</bold>, while vigorous conditions led to the oxidation not only of the primary alcohol of <bold>13</bold> but also of the electron-rich aryl moiety (see <xref ref-type="supplementary-material" rid="SD1">Supporting Information File 1</xref>).</p><fig id="C2" position="float"><label>Scheme 2</label><caption><p>The attempted synthesis of <bold>2</bold> via a stepwise fluorination approach (ether series). THF = tetrahydrofuran, AD-mix-&#x003b1; = commercially available asymmetric dihydroxylation reagent, TBAF = tetrabutylammonium fluoride, DeoxoFluor = bis(2-methoxyethyl)aminosulfur trifluoride.</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g007"/></fig><p>In order to circumvent the troublesome oxidation reaction (i.e., <bold>13&#x02192;14</bold>, <xref ref-type="fig" rid="C2">Scheme 2</xref>), and to seek higher enantiopurity of the target, we modified the synthetic plan to include an ester moiety throughout (<xref ref-type="fig" rid="C3">Scheme 3</xref>). Thus, the &#x003b1;,&#x003b2;-unsaturated ester <bold>15</bold> [<xref rid="R25" ref-type="bibr">25</xref>] was carried through a similar sequence to that previously described, i.e., dihydroxylation, cyclic sulfate formation, ring-opening with TBAF (although note the regioselectivity [<xref rid="R31" ref-type="bibr">31</xref>]), deoxyfluorination, and deprotection to deliver the difluorinated acid <bold>20</bold>. Finally, coupling of the acid <bold>20</bold> with piperidine afforded the target compound <bold>2</bold> in moderate yield (<xref ref-type="fig" rid="C3">Scheme 3</xref>). The enantiopurity of <bold>2</bold> was investigated using chiral HPLC. From a spectroscopically pure sample of <bold>2</bold>, two HPLC peaks were observed, with an integral ratio of 99:1. It is assumed that the two peaks correspond to the two enantiomers of <bold>2</bold> and, if that assumption is true, then the optical purity of this sample is 98% ee.</p><fig id="C3" position="float"><label>Scheme 3</label><caption><p>Synthesis of compound <bold>2</bold> via a stepwise fluorination approach (ester series). DIC = diisopropylcarbodiimide, HOBt = hydroxybenzotriazole, DMF = <italic>N</italic>,<italic>N</italic>-dimethylformamide.</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g008"/></fig></sec><sec><title>Conformational analysis</title><p>Having completed the synthesis of the target molecule <bold>2</bold>, the next task was to investigate the conformational behavior of this molecule. This was achieved by performing a DFT study in the Gaussian software, using the M06-2X level of theory with the 6-311+G(d,p) basis set, parameters similar to those employed by Linclau and co-workers for their studies of vicinal difluoro systems [<xref rid="R22" ref-type="bibr">22</xref>]. A set of starting structures of <bold>2</bold> was generated by systematically rotating three bonds (i.e., F&#x02013;C&#x02013;C&#x02013;F, F&#x02013;C&#x02013;C=O, and O=C&#x02013;N&#x02013;C) in 120&#x000b0; increments and the starting structures were then geometry optimised and their energies calculated. To enable benchmarking against experiment, NMR spin&#x02013;spin coupling constants were calculated for the lowest-energy final structures of <bold>2</bold> using the GIAO method with the B3LYP/6-311+G(d,p) level of theory. Chloroform was used as the solvent for both the NMR experiments and the SMD calculations.</p><p>The three lowest-energy structures to emerge from the computational analysis (i.e., <bold>2a</bold>&#x02013;<bold>c</bold>) are shown in <xref ref-type="fig" rid="F2">Figure 2</xref>. The global minimum structure <bold>2a</bold> has a F&#x02013;C&#x02013;C&#x02013;F dihedral angle of 73&#x000b0;, giving an extended zigzag carbon chain. This approximates rotamer I (<xref ref-type="fig" rid="F1">Figure 1</xref>) and in this regard <bold>2a</bold> is a good conformational mimic of <bold>1</bold>. However, <bold>2a</bold> has a F&#x02013;C&#x02013;C=O dihedral angle of 152&#x000b0;, approximating rotamer III (<xref ref-type="fig" rid="F1">Figure 1</xref>) and in this regard <bold>2a</bold> is a poorer conformational mimic of <bold>1</bold>. The next-higher energy structure (<bold>2b</bold>, <xref ref-type="fig" rid="F2">Figure 2</xref>) is related to <bold>2a</bold> through a ring-flip of the piperidine moiety (equivalent to a 180&#x000b0; rotation of the amide bond). The structures <bold>2a</bold>,<bold>b</bold> are close in energy, suggesting that both puckers of the piperidine moiety would be substantially populated in solution. A similar situation occurs for piperine itself; an indirect evidence for this comes from the crystal structure of <bold>1</bold> (<xref ref-type="fig" rid="F1">Figure 1</xref>), where there is a second molecule in the unit cell (not shown) that has the alternative ring pucker [<xref rid="R14" ref-type="bibr">14</xref>]. The next-higher energy calculated structure of <bold>2</bold> (i.e., <bold>2c</bold>, <xref ref-type="fig" rid="F2">Figure 2</xref>) has a F&#x02013;C&#x02013;C&#x02013;F dihedral angle of &#x02212;52&#x000b0;. This approximates rotamer II (<xref ref-type="fig" rid="F1">Figure 1</xref>), giving a bent carbon chain that contrasts with the extended chains of <bold>2a</bold>,<bold>b</bold>. The structure <bold>2c</bold> has a F&#x02013;C&#x02013;C=O dihedral angle of &#x02212;118&#x000b0;; this approximates rotamer IV (<xref ref-type="fig" rid="F1">Figure 1</xref>). Together, the structures <bold>2a</bold>&#x02013;<bold>c</bold> seem to dominate the conformer population distribution of <bold>2</bold> in chloroform solution, because the weight-averaged calculated <italic>J</italic>-values of <bold>2a</bold>&#x02013;<bold>c</bold> match the experimentally-measured <italic>J</italic>-values quite well (<xref ref-type="fig" rid="F2">Figure 2</xref>). But none of the structures <bold>2a</bold>&#x02013;<bold>c</bold> are a close conformational match with piperine (<bold>1</bold>).</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Conformational analysis of <bold>2</bold> by DFT and NMR. The numbering scheme for NMR spins is given on structure <bold>2a</bold>.</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g003"/></fig><p>A noteworthy feature of structures <bold>2a</bold>,<bold>b</bold> (<xref ref-type="fig" rid="F2">Figure 2</xref>) is that both, the &#x003b1;-fluorine and the &#x003b2;-fluorine atoms of each structure make close contacts with the hydrogen atoms on the piperidine ring (2.08&#x02013;2.34 &#x000c5;). This manifests in the observation of a through-space coupling (<italic>J</italic> = 1.9 Hz) between the &#x003b1;-fluorine and a piperidine hydrogen in the experimental NMR spectrum of <bold>2</bold> (i.e., spins 6/7, <xref ref-type="fig" rid="F2">Figure 2</xref>). The attractive F&#x000b7;&#x000b7;&#x000b7;H interactions might explain why the amide bond is twisted by 11&#x02013;20&#x000b0; from planarity in <bold>2a</bold>,<bold>b</bold>. In structure <bold>2c</bold>, only the &#x003b1;-fluorine makes close contacts with hydrogens on the piperidine ring, and the amide is twisted to a lesser degree in that case (8&#x000b0; away from planarity). It is interesting that in the crystal structure of piperine itself (<bold>1</bold>, <xref ref-type="fig" rid="F1">Figure 1</xref>) [<xref rid="R14" ref-type="bibr">14</xref>], the amide bond is also twisted by 15&#x000b0; away from planarity. In this case the distortion might be attributable to a H&#x000b7;&#x000b7;&#x000b7;H clash (1.99 &#x000c5;).</p><p>Structure <bold>2f</bold> (<xref ref-type="fig" rid="F2">Figure 2</xref>), which was among the higher-energy calculated conformers of <bold>2</bold> (see <xref ref-type="supplementary-material" rid="SD1">Supporting Information File 1</xref>), bears a close resemblance to the solid-state conformation of piperine (<bold>1</bold>, <xref ref-type="fig" rid="F1">Figure 1</xref>). The structure <bold>2f</bold> has a F&#x02013;C&#x02013;C&#x02013;F dihedral angle of 57&#x000b0; and a F&#x02013;C&#x02013;C=O dihedral angle of &#x02013;133&#x000b0;. These angles approximate rotamers I and IV, respectively (<xref ref-type="fig" rid="F1">Figure 1</xref>). The unexpectedly high relative energy that was calculated for compound <bold>2f</bold> might be partially attributable to the fact that it features only a single F&#x000b7;&#x000b7;&#x000b7;H contact within 2.50 &#x000c5;. The calculations suggest that the conformer <bold>2f</bold> is not significantly populated in chloroform solution but it was not possible to verify this by NMR measurements, because <bold>2f</bold> is essentially superimposable with <bold>2a</bold>,<bold>b</bold> within the fluoroalkyl segment. In more polar solvents such as water, the intramolecular F&#x000b7;&#x000b7;&#x000b7;H interactions would be expected to decrease in significance [<xref rid="R32" ref-type="bibr">32</xref>] and this might increase the accessibility of conformer <bold>2f</bold>. We reasoned that comparing the biological activities of <bold>1</bold> vs <bold>2</bold> might shed light on this possibility (vide infra).</p></sec><sec><title>Photostability</title><p>A limitation of piperine (<bold>1</bold>) as a drug lead is its instability under UV light. The conjugated system of <bold>1</bold> is well-known to undergo facile <italic>E</italic>/<italic>Z</italic> isomerization upon the absorption of UV photons, leading rapidly to a mixture of all four possible geometric isomers of <bold>1</bold> [<xref rid="R15" ref-type="bibr">15</xref>&#x02013;<xref rid="R17" ref-type="bibr">17</xref>]. In the present work, this phenomenon was confirmed by exposing an ethanolic solution of <bold>1</bold> to sunlight for 2.5 h (<xref ref-type="fig" rid="F3">Figure 3</xref>). The analysis of the product by <sup>1</sup>H NMR spectroscopy revealed a multitude of new signals in the alkenyl region. In contrast, the analog <bold>2</bold> lacks conjugation in the central portion of the molecule and was therefore expected to be more stable to UV light. Indeed, the exposure of <bold>2</bold> to sunlight in an identical manner to that described for <bold>1</bold> led to no detectable decomposition (<xref ref-type="fig" rid="F3">Figure 3</xref>, <xref ref-type="supplementary-material" rid="SD1">Supporting Information File 1</xref>).</p><fig id="F3" position="float"><label>Figure 3</label><caption><p>Analog <bold>2</bold> has greater stability to UV light than does piperine (<bold>1</bold>).</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g004"/></fig></sec><sec><title>Biological activity and solubility</title><p>The biological activities of piperine (<bold>1</bold>) and the analog <bold>2</bold> were compared using two different assays, namely the inhibition of either acetylcholinesterase (AChE) or &#x003b2;-secretase (BACE-1).</p><p>The inhibition of AChE was measured using a modification of a previously described colorimetric assay (<xref ref-type="fig" rid="F4">Figure 4a</xref>) [<xref rid="R33" ref-type="bibr">33</xref>]. It quickly became apparent that the limited solubility of piperine (<bold>1</bold>) in 50 mM Tris-HCl buffer, even in the presence of methanol as a co-solvent, was a major problem in this assay. We observed cloudiness or the appearance of a precipitate at higher concentrations of <bold>1</bold>, which affected the reproducibility of the assay, and prevented complete inhibition from being achieved (<xref ref-type="fig" rid="F4">Figure 4a</xref>). The estimated IC<sub>50</sub> of <bold>1</bold> was &#x0003e;1,000 &#x003bc;M. In contrast, analog <bold>2</bold> posed no solubility problems in this assay, generating a reproducible curve all the way to complete inhibition and returning an IC<sub>50</sub> value of 51.7 &#x003bc;M. Thus, the replacement of the C=C fragment in <bold>1</bold> with a <italic>threo</italic>-difluoroalkane motif in <bold>2</bold> appears to preserve or enhance the AChE-binding ability, while simultaneously offering the advantage of improved aqueous solubility.</p><fig id="F4" position="float"><label>Figure 4</label><caption><p>Biological activity of piperine (<bold>1</bold>) and derivative <bold>2</bold>. (a) Inihbition of AChE by <bold>1</bold> (IC<sub>50</sub> &#x0003e;1000 &#x003bc;M) and <bold>2</bold> (IC<sub>50</sub> = 51.7 &#x003bc;M) and (b) inhibition of BACE-1 by <bold>1</bold> (IC<sub>50</sub> = 59.2 &#x003bc;M) and <bold>2</bold> (IC<sub>50</sub> &#x0003e; 1000 &#x003bc;M).</p></caption><graphic xlink:href="Beilstein_J_Org_Chem-16-2663-g005"/></fig><p>The inhibition of BACE-1 was measured using a fluorogenic peptide substrate according to an established method (<xref ref-type="fig" rid="F4">Figure 4b</xref>) [<xref rid="R34" ref-type="bibr">34</xref>]. Intriguingly, the relative activities of <bold>1</bold> vs <bold>2</bold> were reversed in comparison with the AChE assay. The lead compound <bold>1</bold> achieved the complete inhibition of BACE-1 under the conditions of the assay, giving an IC<sub>50</sub> value of 59.2 &#x003bc;M. In contrast, analog <bold>2</bold> was a much weaker inhibitor of BACE-1, failing to achieve complete inhibition, and giving an estimated IC<sub>50</sub> value of &#x0003e;1,000 &#x003bc;M.</p><p>There are several conceivable explanations for the reversed relative activities of <bold>1</bold> vs <bold>2</bold> in the AChE vs BACE-1 assays. One possibility is that analog <bold>2</bold> is induced to adopt the &#x0201c;correct&#x0201d; conformation when binding to both targets (i.e., <bold>2f</bold>, <xref ref-type="fig" rid="F2">Figure 2</xref>), and this structure fits well within the AChE active site but poorly within the BACE-1 active site, perhaps due to unfavourable interactions of the fluorine substituents of <bold>2</bold> with BACE-1 active site residues. A second possibility is that <bold>2</bold> adopts an &#x0201c;incorrect&#x0201d; conformation upon binding to both targets (e.g., <bold>2a</bold>, <xref ref-type="fig" rid="F2">Figure 2</xref>), and this novel molecular shape is readily accommodated by AChE [<xref rid="R35" ref-type="bibr">35</xref>] but not by BACE-1, perhaps due to different levels of flexibility within the enzyme active sites. A third possibility is that the analog <bold>2</bold> adopts different conformations upon binding to AChE vs BACE-1, since the microenvironments within the enzymes&#x02019; active sites could be different (e.g., more/less polar), the &#x0201c;correct&#x0201d; binding geometry of <bold>2</bold> might be favoured in AChE but not in BACE-1. These possibilities all remain speculative in the absence of high-resolution structural data of the enzyme&#x02013;ligand complexes.</p></sec></sec><sec><title>Conclusion</title><p>A <italic>threo</italic>-difluorinated piperine analog (<bold>2</bold>) was successfully synthesised through a stepwise route. The physicochemical properties of compound <bold>2</bold> were found to be superior to piperine (<bold>1</bold>) itself in two key respects, namely photostability and aqueous solubility. The conformational analysis of <bold>2</bold> by DFT and NMR spectroscopy revealed that the lowest-energy conformations <bold>2a</bold>&#x02013;<bold>c</bold> are imperfect mimics of <bold>1</bold> but that a somewhat higher-energy conformation (<bold>2f</bold>) is a close match for <bold>1</bold>. A preliminary biological investigation revealed that the analog <bold>2</bold> displays superior inhibitory activity towards AChE but inferior activity towards BACE-1, relative to <bold>1</bold>. While the inhibition of both AChE and BACE-1 is potentially desirable for the purpose of treating Alzheimer&#x02019;s disease, it should be noted that problems have been encountered in clinical trials with BACE-1 as the target [<xref rid="R36" ref-type="bibr">36</xref>], suggesting that the analog <bold>2</bold> might still have relevance in the context of an Alzheimer&#x02019;s treatment. More generally, our finding that the <italic>threo</italic>-difluoroalkane motif is sometimes but not always an effective surrogate for <italic>E</italic>-alkenes suggests that this bioisosteric switch could be exploited more widely in medicinal chemistry as a means of increasing the selectivity of a lead compound towards its desired target.</p></sec><sec sec-type="supplementary-material"><title>Supporting Information</title><supplementary-material content-type="local-data" id="SD1"><label>File 1</label><caption><p>Synthetic procedures, characterization data for novel compounds and copies of spectra; photostability assessment, conformational analysis of compound <bold>2</bold>, and biological assays.</p></caption><media mime-subtype="pdf" mimetype="application" xlink:href="Beilstein_J_Org_Chem-16-2663-s001.pdf" xlink:type="simple" id="d39e1122" position="anchor"/></supplementary-material></sec></body><back><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x000d8;rsted</surname><given-names>H C</given-names></name></person-group><source>J Chem Phys</source><year>1820</year><volume>29</volume><fpage>80</fpage><lpage>82</lpage></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ladenburg</surname><given-names>A</given-names></name><name><surname>Scholtz</surname><given-names>M</given-names></name></person-group><source>Ber Dtsch Chem Ges</source><year>1894</year><volume>27</volume><fpage>2958</fpage><lpage>2960</lpage><pub-id pub-id-type="doi">10.1002/cber.18940270356</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>W W</given-names></name><name><surname>Netz</surname><given-names>D F</given-names></name><name><surname>Seidel</surname><given-names>J L</given-names></name></person-group><source>J Chem Educ</source><year>1993</year><volume>70</volume><fpage>598</fpage><lpage>599</lpage><pub-id pub-id-type="doi">10.1021/ed070p598</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meghwal</surname><given-names>M</given-names></name><name><surname>Goswami</surname><given-names>T K</given-names></name></person-group><source>Phytother Res</source><year>2013</year><volume>27</volume><fpage>1121</fpage><lpage>1130</lpage><pub-id pub-id-type="doi">10.1002/ptr.4972</pub-id><pub-id pub-id-type="pmid">23625885</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Srinivasan</surname><given-names>K</given-names></name></person-group><source>Crit Rev Food Sci Nutr</source><year>2007</year><volume>47</volume><fpage>735</fpage><lpage>748</lpage><pub-id pub-id-type="doi">10.1080/10408390601062054</pub-id><pub-id pub-id-type="pmid">17987447</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manayi</surname><given-names>A</given-names></name><name><surname>Nabavi</surname><given-names>S M</given-names></name><name><surname>Setzer</surname><given-names>W N</given-names></name><name><surname>Jafari</surname><given-names>S</given-names></name></person-group><source>Curr Med Chem</source><year>2018</year><volume>25</volume><fpage>4918</fpage><lpage>4928</lpage><pub-id pub-id-type="doi">10.2174/0929867324666170523120656</pub-id><pub-id pub-id-type="pmid">28545378</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yadav</surname><given-names>V</given-names></name><name><surname>Krishnan</surname><given-names>A</given-names></name><name><surname>Vohora</surname><given-names>D</given-names></name></person-group><source>J Ethnopharmacol</source><year>2020</year><volume>247</volume><fpage>112255</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2019.112255</pub-id><pub-id pub-id-type="pmid">31568819</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smilkov</surname><given-names>K</given-names></name><name><surname>Ackova</surname><given-names>D G</given-names></name><name><surname>Cvetkovski</surname><given-names>A</given-names></name><name><surname>Ruskovska</surname><given-names>T</given-names></name><name><surname>Vidovic</surname><given-names>B</given-names></name><name><surname>Atalay</surname><given-names>M</given-names></name></person-group><source>Curr Pharm Des</source><year>2019</year><volume>25</volume><fpage>1729</fpage><lpage>1739</lpage><pub-id pub-id-type="doi">10.2174/1381612825666190701150803</pub-id><pub-id pub-id-type="pmid">31267856</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>M S</given-names></name><name><surname>Pasha</surname><given-names>I</given-names></name><name><surname>Sultan</surname><given-names>M T</given-names></name><name><surname>Randhawa</surname><given-names>M A</given-names></name><name><surname>Saeed</surname><given-names>F</given-names></name><name><surname>Ahmed</surname><given-names>W</given-names></name></person-group><source>Crit Rev Food Sci Nutr</source><year>2013</year><volume>53</volume><fpage>875</fpage><lpage>886</lpage><pub-id pub-id-type="doi">10.1080/10408398.2011.571799</pub-id><pub-id pub-id-type="pmid">23768180</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chonpathompikunlert</surname><given-names>P</given-names></name><name><surname>Wattanathorn</surname><given-names>J</given-names></name><name><surname>Muchimapura</surname><given-names>S</given-names></name></person-group><source>Food Chem Toxicol</source><year>2010</year><volume>48</volume><fpage>798</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2009.12.009</pub-id><pub-id pub-id-type="pmid">20034530</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Okello</surname><given-names>E J</given-names></name><name><surname>Coleman</surname><given-names>A</given-names></name><name><surname>Seal</surname><given-names>C J</given-names></name></person-group><source>Int J Pharm Sci Res</source><year>2015</year><volume>6</volume><fpage>3726</fpage><lpage>3732</lpage></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pai</surname><given-names>V</given-names></name><name><surname>Chandrashekar</surname><given-names>K S</given-names></name><name><surname>Shreedhara</surname><given-names>C S</given-names></name><name><surname>Pai</surname><given-names>A</given-names></name></person-group><source>Res J Pharm Technol</source><year>2017</year><volume>10</volume><fpage>3506</fpage><lpage>3510</lpage><pub-id pub-id-type="doi">10.5958/0974-360x.2017.00628.x</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x0010c;olovi&#x00107;</surname><given-names>M B</given-names></name><name><surname>Krsti&#x00107;</surname><given-names>D Z</given-names></name><name><surname>Lazarevi&#x00107;-Pa&#x00161;ti</surname><given-names>T D</given-names></name><name><surname>Bond&#x0017e;i&#x00107;</surname><given-names>A M</given-names></name><name><surname>Vasi&#x00107;</surname><given-names>V M</given-names></name></person-group><source>Curr Neuropharmacol</source><year>2013</year><volume>11</volume><fpage>315</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.2174/1570159x11311030006</pub-id><pub-id pub-id-type="pmid">24179466</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>J-R</given-names></name><name><surname>Mei</surname><given-names>X</given-names></name></person-group><source>CrystEngComm</source><year>2017</year><volume>19</volume><issue>41</issue><fpage>6154</fpage><lpage>6163</lpage><pub-id pub-id-type="doi">10.1039/c7ce01468f</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grewe</surname><given-names>R</given-names></name><name><surname>Freist</surname><given-names>W</given-names></name><name><surname>Neumann</surname><given-names>H</given-names></name><name><surname>Kersten</surname><given-names>S</given-names></name></person-group><source>Chem Ber</source><year>1970</year><volume>103</volume><fpage>3752</fpage><lpage>3770</lpage><pub-id pub-id-type="doi">10.1002/cber.19701031204</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Yaoi</surname><given-names>T</given-names></name><name><surname>Koshiba</surname><given-names>H</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><name><surname>Maoka</surname><given-names>T</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Mori</surname><given-names>K</given-names></name></person-group><source>Food Sci Technol Int, Tokyo</source><year>1996</year><volume>2</volume><fpage>24</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.3136/fsti9596t9798.2.24</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozukue</surname><given-names>N</given-names></name><name><surname>Park</surname><given-names>M-S</given-names></name><name><surname>Choi</surname><given-names>S-H</given-names></name><name><surname>Lee</surname><given-names>S-U</given-names></name><name><surname>Ohnishi-Kameyama</surname><given-names>M</given-names></name><name><surname>Levin</surname><given-names>C E</given-names></name><name><surname>Friedman</surname><given-names>M</given-names></name></person-group><source>J Agric Food Chem</source><year>2007</year><volume>55</volume><issue>17</issue><fpage>7131</fpage><lpage>7139</lpage><pub-id pub-id-type="doi">10.1021/jf070831p</pub-id><pub-id pub-id-type="pmid">17661483</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hagan</surname><given-names>D</given-names></name></person-group><source>Chem Soc Rev</source><year>2008</year><volume>37</volume><issue>2</issue><fpage>308</fpage><lpage>319</lpage><pub-id pub-id-type="doi">10.1039/b711844a</pub-id><pub-id pub-id-type="pmid">18197347</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>L</given-names></name></person-group><source>Beilstein J Org Chem</source><year>2010</year><volume>6</volume><fpage>No. 38</fpage><pub-id pub-id-type="doi">10.3762/bjoc.6.38</pub-id><pub-id pub-id-type="pmid">20502650</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meanwell</surname><given-names>N A</given-names></name></person-group><source>J Med Chem</source><year>2018</year><volume>61</volume><fpage>5822</fpage><lpage>5880</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b01788</pub-id><pub-id pub-id-type="pmid">29400967</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gillis</surname><given-names>E P</given-names></name><name><surname>Eastman</surname><given-names>K J</given-names></name><name><surname>Hill</surname><given-names>M D</given-names></name><name><surname>Donnelly</surname><given-names>D J</given-names></name><name><surname>Meanwell</surname><given-names>N A</given-names></name></person-group><source>J Med Chem</source><year>2015</year><volume>58</volume><fpage>8315</fpage><lpage>8359</lpage><pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00258</pub-id><pub-id pub-id-type="pmid">26200936</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fox</surname><given-names>S J</given-names></name><name><surname>Gourdain</surname><given-names>S</given-names></name><name><surname>Coulthurst</surname><given-names>A</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Kuprov</surname><given-names>I</given-names></name><name><surname>Essex</surname><given-names>J W</given-names></name><name><surname>Skylaris</surname><given-names>C-K</given-names></name><name><surname>Linclau</surname><given-names>B</given-names></name></person-group><source>Chem &#x02013; Eur J</source><year>2015</year><volume>21</volume><issue>4</issue><fpage>1682</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1002/chem.201405317</pub-id><pub-id pub-id-type="pmid">25418601</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tormena</surname><given-names>C F</given-names></name><name><surname>Rittner</surname><given-names>R</given-names></name><name><surname>Abraham</surname><given-names>R J</given-names></name><name><surname>Basso</surname><given-names>E A</given-names></name><name><surname>Pontes</surname><given-names>R M</given-names></name></person-group><source>J Chem Soc, Perkin Trans 2</source><year>2000</year><fpage>2054</fpage><lpage>2059</lpage><pub-id pub-id-type="doi">10.1039/b004685j</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>S M</given-names></name><name><surname>Medley</surname><given-names>J W</given-names></name><name><surname>Jacobsen</surname><given-names>E N</given-names></name></person-group><source>J Am Chem Soc</source><year>2016</year><volume>138</volume><fpage>5000</fpage><lpage>5003</lpage><pub-id pub-id-type="doi">10.1021/jacs.6b02391</pub-id><pub-id pub-id-type="pmid">27046019</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ara&#x000fa;jo J&#x000fa;nior</surname><given-names>J X</given-names></name><name><surname>Barreiro</surname><given-names>E J</given-names></name><name><surname>Parente</surname><given-names>J P</given-names></name><name><surname>Fraga</surname><given-names>C A M</given-names></name></person-group><source>Synth Commun</source><year>1999</year><volume>29</volume><issue>2</issue><fpage>263</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1080/00397919908085766</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>M</given-names></name><name><surname>O'Hagan</surname><given-names>D</given-names></name><name><surname>Slawin</surname><given-names>A M Z</given-names></name></person-group><source>J Am Chem Soc</source><year>2005</year><volume>127</volume><issue>2</issue><fpage>482</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1021/ja045299q</pub-id><pub-id pub-id-type="pmid">15643846</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunter</surname><given-names>L</given-names></name><name><surname>Jolliffe</surname><given-names>K A</given-names></name><name><surname>Jordan</surname><given-names>M J T</given-names></name><name><surname>Jensen</surname><given-names>P</given-names></name><name><surname>Macquart</surname><given-names>R B</given-names></name></person-group><source>Chem &#x02013; Eur J</source><year>2011</year><volume>17</volume><fpage>2340</fpage><lpage>2343</lpage><pub-id pub-id-type="doi">10.1002/chem.201003320</pub-id><pub-id pub-id-type="pmid">21254269</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Ara&#x000fa;jo-J&#x000fa;nior</surname><given-names>J X</given-names></name><name><surname>de M. Duarte</surname><given-names>C</given-names></name><name><surname>de O. Chaves</surname><given-names>M C</given-names></name><name><surname>Parente</surname><given-names>J P</given-names></name><name><surname>Fraga</surname><given-names>C A M</given-names></name><name><surname>Barreiro</surname><given-names>E J</given-names></name></person-group><source>Synth Commun</source><year>2001</year><volume>31</volume><fpage>117</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1081/scc-100000187</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bresciani</surname><given-names>S</given-names></name><name><surname>O&#x02019;Hagan</surname><given-names>D</given-names></name></person-group><source>Tetrahedron Lett</source><year>2010</year><volume>51</volume><fpage>5795</fpage><lpage>5797</lpage><pub-id pub-id-type="doi">10.1016/j.tetlet.2010.08.104</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>M K</given-names></name><name><surname>Ugaz</surname><given-names>C R</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Doyle</surname><given-names>A G</given-names></name></person-group><source>J Am Chem Soc</source><year>2015</year><volume>137</volume><fpage>9571</fpage><lpage>9574</lpage><pub-id pub-id-type="doi">10.1021/jacs.5b06307</pub-id><pub-id pub-id-type="pmid">26177230</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Sharpless</surname><given-names>K B</given-names></name></person-group><source>J Am Chem Soc</source><year>1988</year><volume>110</volume><fpage>7538</fpage><lpage>7539</lpage><pub-id pub-id-type="doi">10.1021/ja00230a045</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>I</given-names></name><name><surname>Jordan</surname><given-names>M J T</given-names></name><name><surname>Gavande</surname><given-names>N</given-names></name><name><surname>Doddareddy</surname><given-names>M R</given-names></name><name><surname>Chebib</surname><given-names>M</given-names></name><name><surname>Hunter</surname><given-names>L</given-names></name></person-group><source>Chem Commun</source><year>2012</year><volume>48</volume><fpage>829</fpage><lpage>831</lpage><pub-id pub-id-type="doi">10.1039/c1cc15816c</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathew</surname><given-names>M</given-names></name><name><surname>Subramanian</surname><given-names>S</given-names></name></person-group><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e86804</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0086804</pub-id><pub-id pub-id-type="pmid">24466247</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Salvador</surname><given-names>L A</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Felsenstein</surname><given-names>K M</given-names></name><name><surname>Ladd</surname><given-names>T B</given-names></name><name><surname>Price</surname><given-names>A R</given-names></name><name><surname>Golde</surname><given-names>T E</given-names></name><etal/></person-group><source>J Med Chem</source><year>2012</year><volume>55</volume><issue>23</issue><fpage>10749</fpage><lpage>10765</lpage><pub-id pub-id-type="doi">10.1021/jm301630s</pub-id><pub-id pub-id-type="pmid">23181502</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul Manap</surname><given-names>A S</given-names></name><name><surname>Wei Tan</surname><given-names>A C</given-names></name><name><surname>Leong</surname><given-names>W H</given-names></name><name><surname>Yin Chia</surname><given-names>A Y</given-names></name><name><surname>Vijayabalan</surname><given-names>S</given-names></name><name><surname>Arya</surname><given-names>A</given-names></name><name><surname>Wong</surname><given-names>E H</given-names></name><name><surname>Rizwan</surname><given-names>F</given-names></name><name><surname>Bindal</surname><given-names>U</given-names></name><name><surname>Koshy</surname><given-names>S</given-names></name><etal/></person-group><source>Front Aging Neurosci</source><year>2019</year><volume>11</volume><fpage>10.3389/fnagi.2019.00206</fpage><pub-id pub-id-type="doi">10.3389/fnagi.2019.00206</pub-id><pub-id pub-id-type="pmid">30760998</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moussa&#x02010;Pacha</surname><given-names>N M</given-names></name><name><surname>Abdin</surname><given-names>S M</given-names></name><name><surname>Omar</surname><given-names>H A</given-names></name><name><surname>Alniss</surname><given-names>H</given-names></name><name><surname>Al&#x02010;Tel</surname><given-names>T H</given-names></name></person-group><source>Med Res Rev</source><year>2020</year><volume>40</volume><issue>1</issue><fpage>339</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1002/med.21622</pub-id><pub-id pub-id-type="pmid">31347728</pub-id></element-citation></ref></ref-list></back></article>